Practical guidelines for physicians in the management of febrile seizures

Recent studies have shown that adequate medication can prevent the recurrence of febrile seizures (FS). It has also been clarified that the vast majority of, though not all, FS patients follow a benign course. Then, questions arise as to whether or not FS should be prevented, particularly in light o...

Full description

Saved in:
Bibliographic Details
Published in:Brain & development (Tokyo. 1979) 1996-11, Vol.18 (6), p.479-484
Main Authors: Fukuyama, Yukio, Seki, Tohru, Ohtsuka, Chikaya, Miura, Hisao, Hara, Michiko
Format: Article
Language:English
Subjects:
Biological and medical sciences
Diazepam suppository
Febrile seizure
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Intermittent therapy
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Physician's guideline
Practice Guidelines as Topic
Prophylaxis
Risk factor
Seizures, Febrile - diagnosis
Seizures, Febrile - prevention & control
Seizures, Febrile - therapy
Warning factor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent studies have shown that adequate medication can prevent the recurrence of febrile seizures (FS). It has also been clarified that the vast majority of, though not all, FS patients follow a benign course. Then, questions arise as to whether or not FS should be prevented, particularly in light of the risks of side effects from drugs. Which kinds of FS can be prevented, if necessary? The guidelines presented here are aimed primarily at helping general practitioners in considering how to manage FS most appropriately. The guidelines stress that judgements should be individualized, while referring to a few specific ‘warning factors’. The guidelines follow a ‘laissez-faire’ principle for the majority of FS cases, whereas intermittent therapy with diazepam and continuous medication with either phenobarbital or valproate are indicated in other limited cases meeting respective definite criteria.
ISSN:0387-7604
1872-7131
DOI:10.1016/S0387-7604(96)00066-6